Maintenance Notice (2:00 - 4:00 AM July 12, 2026 UTC): The website is scheduled for maintenance. The website will be available, but some functions may experience errors. We appreciate your patience and understanding.
Product Document Searching Made Easy by 2D Code! | TCI Life Science News July 2026 | [Product Highlights] Mitochondrial Membrane Potential... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
CAS RN: 121268-17-5 | Product Number: A2456
Alendronate Sodium Trihydrate
Purity: >97.0%(T)
- Alendronic Acid Monosodium Salt Trihydrate
- (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonic Acid Monosodium Salt Trihydrate
- Monosodium (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonate Trihydrate
* ChemSupply Australia Pty Ltd (Phone: 08-8440-2000 / email: sales@chemsupply.com.au)
| Product Number | A2456 |
Purity / Analysis Method
|
>97.0%(T) |
| Molecular Formula / Molecular Weight | C__4H__1__2NNaO__7P__2·3H__2O = 325.13 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 121268-17-5 |
Related CAS RN
|
66376-36-1&129318-43-0 |
| Reaxys Registry Number | 6947932 |
| PubChem Substance ID | 135727181 |
| Merck Index (14) | 229 |
| MDL Number | MFCD01748233 |
| Appearance | White to Almost white powder to crystal |
| Purity(Neutralization titration) | min. 97.0 % |
| Drying loss | 16.1 to 17.1 % |
| NMR | confirm to structure |
| Solubility in water | Slightly soluble |
| Solubility (insoluble in) | Chloroform |
| RTECS# | SZ6523666 |
| H.S.code* | 2931.49-000 |
References
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
- Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies
- Synthesis and Study of Alendronate Derivatives as Potential Prodrugs of Alendronate Sodium for the Treatment of Low Bone Density and Osteoporosis
References
- 1)Anti-bone resorption
- a)J. E. Dunford, K. Thompson, F. P. Coxon, S. P. Luckman, F. M. Hahn, C. D. Poulter, F. H. Ebetino, M. J. Rogers., J. Pharmacol. Exp. Ther. 2001, 296, 235.
- b)E. Hiroi-Furuya, T. Kameda, K. Hiura, H. Mano, K. Miyazawa, Y. Nakamaru, M. Watanabe-Mano, N. Okuda, J. Shimada, Y. Yamamoto, Y. Hakeda, M. Kumegawa, Calcif. Tissue Int. 1999, 64, 219.

Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.